Skip to content

Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection

Investigators identify genetic profile associated with better treatment outcomes in people with HIV/HCV co-infection

This World Hepatitis Day – visit infohep.org

This World Hepatitis Day – visit infohep.org

Number of patients diagnosed with HCV in England increased by a third between 2010 and 2012

HIV/HCV co-infected people can do well on hepatitis C triple therapy despite contraindications

Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people

Juan Macías of Hospital Universitario de Valme in Seville, Spain. © Liz Highleyman / hivandhepatitis.com

Southern African study shows tenofovir associated with lower risk of HBV resistance than 3TC among HIV-HBV-co-infected people starting antiretroviral therapy

AbbVie interferon-free hepatitis C combo works well with reduced ribavirin dose

Experts discuss role of drug policy in HIV, hepatitis and TB epidemics

Adeeba Kamarulzaman of the University of Malaya speaking at IAS. Photo ©International AIDS Society/Marcus Rose/Workers' Photos